Towards reduction in bias in epidemic curves due to outcome misclassification through Bayesian analysis of time-series of laboratory test results: case study of COVID-19 in Alberta, Canada and Philadelphia, USA

Abstract Background Despite widespread use, the accuracy of the diagnostic test for SARS-CoV-2 infection is poorly understood. The aim of our work was to better quantify misclassification errors in identification of true cases of COVID-19 and to study the impact of these errors in epidemic curves us...

Full description

Bibliographic Details
Main Authors: Igor Burstyn, Neal D. Goldstein, Paul Gustafson
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Medical Research Methodology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12874-020-01037-4
_version_ 1818257782019719168
author Igor Burstyn
Neal D. Goldstein
Paul Gustafson
author_facet Igor Burstyn
Neal D. Goldstein
Paul Gustafson
author_sort Igor Burstyn
collection DOAJ
description Abstract Background Despite widespread use, the accuracy of the diagnostic test for SARS-CoV-2 infection is poorly understood. The aim of our work was to better quantify misclassification errors in identification of true cases of COVID-19 and to study the impact of these errors in epidemic curves using publicly available surveillance data from Alberta, Canada and Philadelphia, USA. Methods We examined time-series data of laboratory tests for SARS-CoV-2 viral infection, the causal agent for COVID-19, to try to explore, using a Bayesian approach, the sensitivity and specificity of the diagnostic test. Results Our analysis revealed that the data were compatible with near-perfect specificity, but it was challenging to gain information about sensitivity. We applied these insights to uncertainty/bias analysis of epidemic curves under the assumptions of both improving and degrading sensitivity. If the sensitivity improved from 60 to 95%, the adjusted epidemic curves likely falls within the 95% confidence intervals of the observed counts. However, bias in the shape and peak of the epidemic curves can be pronounced, if sensitivity either degrades or remains poor in the 60–70% range. In the extreme scenario, hundreds of undiagnosed cases, even among the tested, are possible, potentially leading to further unchecked contagion should these cases not self-isolate. Conclusion The best way to better understand bias in the epidemic curves of COVID-19 due to errors in testing is to empirically evaluate misclassification of diagnosis in clinical settings and apply this knowledge to adjustment of epidemic curves.
first_indexed 2024-12-12T17:49:07Z
format Article
id doaj.art-5e88e27c384b4202b8d409bc2252eac0
institution Directory Open Access Journal
issn 1471-2288
language English
last_indexed 2024-12-12T17:49:07Z
publishDate 2020-06-01
publisher BMC
record_format Article
series BMC Medical Research Methodology
spelling doaj.art-5e88e27c384b4202b8d409bc2252eac02022-12-22T00:16:51ZengBMCBMC Medical Research Methodology1471-22882020-06-0120111010.1186/s12874-020-01037-4Towards reduction in bias in epidemic curves due to outcome misclassification through Bayesian analysis of time-series of laboratory test results: case study of COVID-19 in Alberta, Canada and Philadelphia, USAIgor Burstyn0Neal D. Goldstein1Paul Gustafson2Department of Environmental and Occupational Health, Drexel University Dornsife School of Public HealthDepartment of Epidemiology & Biostatistics, Drexel University Dornsife School of Public HealthDepartment of Statistics, University of British ColumbiaAbstract Background Despite widespread use, the accuracy of the diagnostic test for SARS-CoV-2 infection is poorly understood. The aim of our work was to better quantify misclassification errors in identification of true cases of COVID-19 and to study the impact of these errors in epidemic curves using publicly available surveillance data from Alberta, Canada and Philadelphia, USA. Methods We examined time-series data of laboratory tests for SARS-CoV-2 viral infection, the causal agent for COVID-19, to try to explore, using a Bayesian approach, the sensitivity and specificity of the diagnostic test. Results Our analysis revealed that the data were compatible with near-perfect specificity, but it was challenging to gain information about sensitivity. We applied these insights to uncertainty/bias analysis of epidemic curves under the assumptions of both improving and degrading sensitivity. If the sensitivity improved from 60 to 95%, the adjusted epidemic curves likely falls within the 95% confidence intervals of the observed counts. However, bias in the shape and peak of the epidemic curves can be pronounced, if sensitivity either degrades or remains poor in the 60–70% range. In the extreme scenario, hundreds of undiagnosed cases, even among the tested, are possible, potentially leading to further unchecked contagion should these cases not self-isolate. Conclusion The best way to better understand bias in the epidemic curves of COVID-19 due to errors in testing is to empirically evaluate misclassification of diagnosis in clinical settings and apply this knowledge to adjustment of epidemic curves.http://link.springer.com/article/10.1186/s12874-020-01037-4EpidemicBias analysisUncertaintySimulationUnder-diagnosisSensitivity
spellingShingle Igor Burstyn
Neal D. Goldstein
Paul Gustafson
Towards reduction in bias in epidemic curves due to outcome misclassification through Bayesian analysis of time-series of laboratory test results: case study of COVID-19 in Alberta, Canada and Philadelphia, USA
BMC Medical Research Methodology
Epidemic
Bias analysis
Uncertainty
Simulation
Under-diagnosis
Sensitivity
title Towards reduction in bias in epidemic curves due to outcome misclassification through Bayesian analysis of time-series of laboratory test results: case study of COVID-19 in Alberta, Canada and Philadelphia, USA
title_full Towards reduction in bias in epidemic curves due to outcome misclassification through Bayesian analysis of time-series of laboratory test results: case study of COVID-19 in Alberta, Canada and Philadelphia, USA
title_fullStr Towards reduction in bias in epidemic curves due to outcome misclassification through Bayesian analysis of time-series of laboratory test results: case study of COVID-19 in Alberta, Canada and Philadelphia, USA
title_full_unstemmed Towards reduction in bias in epidemic curves due to outcome misclassification through Bayesian analysis of time-series of laboratory test results: case study of COVID-19 in Alberta, Canada and Philadelphia, USA
title_short Towards reduction in bias in epidemic curves due to outcome misclassification through Bayesian analysis of time-series of laboratory test results: case study of COVID-19 in Alberta, Canada and Philadelphia, USA
title_sort towards reduction in bias in epidemic curves due to outcome misclassification through bayesian analysis of time series of laboratory test results case study of covid 19 in alberta canada and philadelphia usa
topic Epidemic
Bias analysis
Uncertainty
Simulation
Under-diagnosis
Sensitivity
url http://link.springer.com/article/10.1186/s12874-020-01037-4
work_keys_str_mv AT igorburstyn towardsreductioninbiasinepidemiccurvesduetooutcomemisclassificationthroughbayesiananalysisoftimeseriesoflaboratorytestresultscasestudyofcovid19inalbertacanadaandphiladelphiausa
AT nealdgoldstein towardsreductioninbiasinepidemiccurvesduetooutcomemisclassificationthroughbayesiananalysisoftimeseriesoflaboratorytestresultscasestudyofcovid19inalbertacanadaandphiladelphiausa
AT paulgustafson towardsreductioninbiasinepidemiccurvesduetooutcomemisclassificationthroughbayesiananalysisoftimeseriesoflaboratorytestresultscasestudyofcovid19inalbertacanadaandphiladelphiausa